Reminiscence B cells play a important function to offer long-term immunity after a vaccination or an infection. Researchers have now described a definite and novel subset of reminiscence B cells that predict long-lived antibody responses to influenza vaccination in people. These effector reminiscence B cells look like poised for a speedy serum antibody response upon secondary problem one 12 months later.